Overview
Yaqi Duan practices in Wuhan, China. Duan is rated as an Experienced expert by MediFind in the treatment of Erdheim-Chester Disease. Their top areas of expertise are Triple-Negative Breast Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Myofibroblastic Tumor, and Rosai-Dorfman Disease.
Their clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Erdheim-Chester Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiosarcomaDuan isExperienced. Learn about Angiosarcoma.
- COVID-19Duan isExperienced. Learn about COVID-19.
- End-Stage Renal Disease (ESRD)
- Erdheim-Chester DiseaseDuan isExperienced. Learn about Erdheim-Chester Disease.
- Inflammatory Myofibroblastic Tumor
- LiposarcomaDuan isExperienced. Learn about Liposarcoma.